This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Follow-up and monitoring for people with OSAHS (obstructive sleep apnoea/hypopnoea syndrome)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Follow-up and monitoring for people with OSAHS (obstructive sleep apnoea/hypopnoea syndrome)

Tailor follow-up to the person's overall treatment plan, which may include lifestyle changes and treating comorbidities

Follow-up for people using continuous positive airway pressure (CPAP)

  • offer face-to-face, video or phone consultations, including review of telemonitoring data (if available), to people with OSAHS having CPAP. This should include:
    • an initial consultation within 1 month and
    • subsequent follow-up according to the person's needs and until optimal control of symptoms and apnoea-hypopnoea index (AHI) or oxygen desaturation index (ODI) is achieved
  • once CPAP is optimised, consider annual follow-up for people with OSAHS
  • offer people with OSAHS having CPAP access to a sleep service for advice, support and equipment between follow-up appointments

Follow-up for people using mandibular advancement splints

  • offer face-to-face, video or phone consultations, including review of downloads from the device (if available), to people with OSAHS using a mandibular advancement splint. This should include:
    • initial follow-up to review adjustment of the device and symptom improvement at 3 months and
    • subsequent follow-up according to the person's needs and until optimal control of symptoms and AHI or ODI is achieved

Follow-up for people using positional modifiers

  • offer face-to-face, video or phone consultations, including review of downloads from the device (if available), to people with OSAHS using a positional modifier
  • this should include:
    • an initial consultation within 3 months and
    • subsequent follow-up according to the person's needs until optimal control of symptoms and AHI or ODI is achieved

Follow-up for people who have had surgery

  • offer people with OSAHS who have had surgery:
    • an initial follow-up consultation with respiratory polygraphy within 3 months of the operation and
    • subsequent follow-up according to the person's needs

Follow-up for drivers with excessive sleepiness

Monitoring treatment efficacy for people with obesity hypoventilation syndrome (OHS)


Assess the effectiveness of treatment with CPAP or non-invasive ventilation in people with OHS by reviewing the following:

  • OHS symptoms, including the Epworth Sleepiness Scale and vigilance, for example, when driving
  • severity of OSAHS, using AHI or ODI
  • improvement in oxygenation and hypercapnia while awake and asleep
  • adherence to therapy
  • telemonitoring or download information from the device (if available)

Explore with the person their understanding and experience of treatment, and review the following:

  • mask type and fit, including checking for leaks
  • nasal and mouth dryness, and the need for humidification
  • other factors affecting sleep disturbance such as insomnia, restless legs and shift work
  • sleep hygiene
  • cleaning and maintenance of equipment

For people with OHS having supplemental oxygen therapy, review whether this is still needed after treatment with non-invasive ventilation or CPAP has been optimised.

 

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.